John R. Pinion II
Overview
John R. Pinion II received an average of $3M in total compensation, including $372K in salary, at Ultragenyx Pharmaceutical from 2015 to 2019.
2019Ultragenyx PharmaceuticalChief Quality Officer and Executive Vice President, Translational Sciences
2018Ultragenyx PharmaceuticalChief Quality Officer and Executive Vice President, Translational Sciences
2017Ultragenyx PharmaceuticalChief Quality Officer and Executive Vice President of Translational Sciences
2016Ultragenyx PharmaceuticalChief Quality Operations Officer and Executive Vice President Analytical Sciences and Research
2015Ultragenyx PharmaceuticalChief Quality Operations Officer and Executive Vice President Analytical Sciences and Research
Source: SEC filings on April 29, 2020, April 27, 2018, and April 28, 2017.
Related executives
We found nine more executives who work or worked at Ultragenyx Pharmaceutical.
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officer and Executive Vice President
Wladimir Hogenhuis
Ultragenyx Pharmaceutical
Chief Operating Officer
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
Dennis Huang
Ultragenyx Pharmaceutical